Business
CSL and research partners give up on plans to develop COVID treatment – Sydney Morning Herald
Australia’s local vaccine producer and its partners have been forced to shelve research on a possible COVID treatment after its phase 3 trial failed to convince…
While the results of this particular clinical trial are disappointing, we are proud that as an industry we proactively and collaboratively pursued this work, and that the program may contribute to a growing understanding of this challenging virus and strategies for patient care, said Bill Mezzanotte, executive vice president and head of research and development and chief medical officer at CSL Behring.
Since we embarked on this development program, and throughout the pandemic, we have learned much…
-
General16 hours agoAccused of Antisemitism: Herald Sun, Israel lobby v Dandenong Clr Rhonda Garad
-
Noosa News16 hours agoMitch Power Quick Shear event gets men talking about mental health
-
General11 hours agoAFL Round 18 live updates: Bulldogs vs Crows, Giants vs Cats, Tigers vs Bombers, Dockers vs Hawks — blog, scores and stats
-
General6 hours agoWallaroos fall to Black Ferns 37-12 in Wellington Test